Instructions
|
- Please read the instructions and enter your author tag here:
|
|
Overview Statement
|
- Is this an over-the-counter medicine?
|
|
- Please enter the generic name here:
|
|
- Please indicate the class to which the drug belongs:
|
|
- Please describe the indications approved by the FDA:
- Check the "Indications and Usage" section from the label
- Fit the context: (Drug name) is (a/an) (category a, category b, and category c) that is FDA approved for the treatment/prophylaxis/diagnosis/procedure of (indication a, indication b, and indication c).
|
|
- Is there a black box warning associated with the drug?
|
|
- Please list the common adverse reactions associated with the drug:
- Collect adverse reactions from the "Highlights of Prescribing Information" section
- Fit the context: Common adverse reactions include (reaction a, reaction b, and reaction c).
|
|
Black Box Warning
|
- Please enter the title of the black box warning:
|
|
- Please enter the body of the black box warning:
|
|
Adult Indications and Dosage
|
- Please enter FDA-labeled indications and dosing information for adults:
- Add information from the "Indications and Usage" and "Dosage And Administration" sections
|
|
- Please enter guideline-supported off-label use in this field:
|
|
- Please enter non–guideline-supported off-label use in this field:
|
|
Pediatric Indications and Dosage
|
- Please enter FDA-labeled indications and dosage information for children:
- Add information from the "Indications and Usage" and "Dosage And Administration" sections
|
|
- Please enter guideline-supported off-label use in this field:
|
|
- Please enter non–guideline-supported off-label use in this field:
|
|
Contraindications
|
- Please enter the FDA reported contraindications:
|
|
Warnings
|
- Please enter the FDA reported warnings associated with the drug:
|
|
Adverse Reactions
|
- Please enter the adverse reactions provided in the "Clinical Trials Experience" section:
|
|
- Please enter the adverse reactions provided in the "Postmarketing Experience" section:
|
|
Drug Interactions
|
- Please enter established drug interactions:
|
|
Use in Specific Populations
|
- Please enter information related to the FDA pregnancy category:
|
|
- Please enter information related to the use of the drug during labor and delivery:
|
|
- Please enter information related to the use of the drug during nursing:
|
|
- Please enter information related to the use of the drug in pediatrics:
|
|
- Please enter information related to the use of the drug in geriatrics:
|
|
- Please enter information related to the use of the drug and gender:
|
|
- Please enter information related to the use of the drug and race:
|
|
- Please enter information related to the use of the drug in patients with renal impairment:
|
|
- Please enter information related to the use of the drug in patients with hepatic impairment:
|
|
- Please enter information related to the use of the drug in females of reproductive potential and males:
|
|
- Please enter information related to the use of the drug in immunocompromised patients:
|
|
- Please enter information related to the use of the drug in other conditions:
|
Title of Others section: Body of Others section:
|
Administration and Monitoring
|
- Please enter information pertaining to routes of administration here:
|
|
- Please enter information pertaining to the monitoring here:
|
|
Overdose
|
- Please enter information pertaining to the drug overdose here:
|
|
Pharmacology
|
- Please enter the DrugBox2 template here:
- Construct the Drugbox2 template based on the original drugbox template
- Harvest the structure image from PubChem
- Rename and upload the image to accommodate the Drugbox2 template
|
|
- Please enter information related to the mechanism of action:
|
|
- Please enter information related to the structure:
[[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
|
|
- Please enter information related to the pharmacodynamics:
|
|
- Please enter information related to the pharmacokinetics:
|
|
- Please enter information related to the nonclinical toxicology:
|
|
Clinical Studies
|
- Please enter information pertaining to the clinical studies of the drug:
|
|
How Supplied
|
- Please enter information pertaining to how the drug is supplied:
|
|
Patient Counseling Information
|
- Please enter the Patient Counseling Information here:
|
|
Precautions with Alcohol
|
- Please enter the information pertaining to concurrent use of the drug with alcohol:
|
|
Brand Names
|
- Please enter the brand names here:
|
|
Look-Alike Drug Names
|
- Please enter look-alike names that could be confused with the drug:
|
|
Package and Label Display Panel
|
- Please enter the Package and Label Display Panel here:
[[File:XXXXX.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
|
|